Viral Genomics
Evolutionary adaptation enabled Tupaia adenovirus to expand host potential
Published in Gene Therapy Weekly, October 2nd, 2003
"Adenoviruses are globally spread and infect species in all five taxons of vertebrates. Outstanding attention is focused on adenoviruses because of their transformation potential, their possible usability as vectors in gene therapy and their applicability in studies dealing with, e.g., cell cycle control, DNA replication, transcription, splicing, virus-host interactions, apoptosis, and viral evolution," scientists in Germany report.
"The accumulation of genetic data provides the basis for the increase of our knowledge about adenoviruses. The Tupaia adenovirus (TAV) infects...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2003-10-02)
More Articles from Gene Therapy Weekly
- Stem-Cell Research
A novel technique enhances embryonic and neuronal stem-cell labeling - Virology
Recombinant adeno-associated virus serotype 1 vectors can transduce nerve cells - Angiology
Polymer-coated stents offer a way to delivery gene therapy to immune cells - Gene Transfer
Cancer cells undergo self destruction with inducible caspase treatment - Neuroscience
Ex vivo neurotrophin gene transfer improves recovery from spinal cord injury - Vector Development
The SV40 enhancer augments nonviral gene delivery - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
